CPO107

· Conjupro Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPO107, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma [Phase 1]

See pricing